ScoreWhy is Metropolis Healthcare Ltd ?
1
High Management Efficiency with a high ROE of 16.21%
2
Company has a low Debt to Equity ratio (avg) at 0.08 times
3
Poor long term growth as Net Sales has grown by an annual rate of 11.48% and Operating profit at 3.94% over the last 5 years
4
Positive results in Sep 25
- OPERATING CF(Y) Highest at Rs 275.01 Cr
- OPERATING PROFIT TO INTEREST(Q) Highest at 19.05 times
- NET SALES(Q) Highest at Rs 429.19 cr
5
With ROE of 11, it has a Expensive valuation with a 7 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -8.99%, its profits have risen by 6.9% ; the PEG ratio of the company is 11.1
6
High Institutional Holdings at 45.62%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Below par performance in long term as well as near term
- Along with generating -8.99% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Metropolis Healt should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Metropolis Healt for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Metropolis Healt
-8.99%
-0.29
30.58%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.48%
EBIT Growth (5y)
3.94%
EBIT to Interest (avg)
12.42
Debt to EBITDA (avg)
0.72
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.98
Tax Ratio
24.59%
Dividend Payout Ratio
16.03%
Pledged Shares
1.18%
Institutional Holding
45.62%
ROCE (avg)
28.03%
ROE (avg)
16.21%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
63
Industry P/E
81
Price to Book Value
6.96
EV to EBIT
47.42
EV to EBITDA
30.35
EV to Capital Employed
6.49
EV to Sales
6.80
PEG Ratio
11.08
Dividend Yield
0.21%
ROCE (Latest)
13.69%
ROE (Latest)
11.05%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
OPERATING CF(Y)
Highest at Rs 275.01 Cr
OPERATING PROFIT TO INTEREST(Q)
Highest at 19.05 times
NET SALES(Q)
Highest at Rs 429.19 cr
PBDIT(Q)
Highest at Rs 108.23 cr.
PBT LESS OI(Q)
Highest at Rs 70.14 cr.
PAT(Q)
Highest at Rs 52.67 cr.
EPS(Q)
Highest at Rs 10.17
-5What is not working for the Company
DPS(Y)
Lowest at Rs 0.00
DPR(Y)
Lowest at 0.00%
DEBT-EQUITY RATIO(HY)
Highest at 0.70 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.84 times
Loading Valuation Snapshot...
Here's what is working for Metropolis Healt
Operating Cash Flow - Annually
Highest at Rs 275.01 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 19.05 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 70.14 cr has Grown at 55.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 45.21 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Highest at Rs 429.19 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 429.19 cr has Grown at 22.3% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 350.98 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 108.23 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 70.14 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 52.67 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 52.67 cr has Grown at 38.5% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 38.02 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 10.17
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Metropolis Healt
Debt-Equity Ratio - Half Yearly
Highest at 0.70 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio- Half Yearly
Lowest at 0.84 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Dividend per Share (DPS) - Annually
Lowest at Rs 0.00
in the last five yearsMOJO Watch
Company is distributing lower dividend than previous years
DPS (Rs)
Dividend Payout Ratio (DPR) - Annually
Lowest at 0.00%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
